Background. Several Arizona tribal lands are highly endemic for the potentially deadly tickborne disease Rocky Mountain spotted fever (RMSF). In 2017, state public health officials were concerned with the underreporting of RMSF in our rural American Indian (AI) community. Surveillance of RMSF using serologic methods requires two samples-a baseline (acute) titer and a second (convalescent) titer two to 4 weeks later. Patient return rates are low, leading to poor understanding of disease burden. Our hospital serves a predominantly AI population that is spread across a large geographic area, with limited access to reliable transportation.
number of titers sent to state lab increased over 13-fold from 2017 to 2018. The system facilitated laboratory follow-up resulting in 61% of samples sent as pairs (acute + convalescent), compared with 36% of samples paired in 2017 (Figure 3) .
Conclusion. This multidisciplinary process led to improved case identification, improved testing efficiency and sustainable surveillance for RMSF. There was a marked increase in RMSF cases detected at our site, an increase in the number of samples tested and the percent of paired samples obtained during 2018. Beyond this relative improvement, the success rate in paired titers is now the highest in Arizona State, where approximately 40% of samples are paired. There is a need for practical and integrated systems to more accurately test and track cases of RMSF in highly endemic, rural areas. Working together across departments was crucial to address challenges and provide solutions, and led to the success of the model. This process provides a model framework for inter-departmental collaboration and develops a unique system to improve both patient care and education to healthcare workers and the community.
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No reported disclosures. Saturday, October 5, 2019: 12:15 PM Background. Respiratory specimens help inform the treatment of hospital-acquired pneumonia (HAP), permitting clinicians to ensure effective and, ideally, narrow-spectrum antibiotic therapy. Here, we examine changes in antibiotic regimens to treat HAP based on the antibiotic susceptibility of pathogens recovered from respiratory samples.
Influence of Microbiological Culture Results on Antibiotic Choice for
Methods. At a single Veterans Affairs (VA) Medical Center, we identified veterans hospitalized between October 2014 and September 2018 with HAP, defined as a clinical respiratory sample obtained >48 hours after admission and corresponding clinical signs and symptoms. Exclusion criteria were death, transfer to hospice care or discharge within 48 hours of sample collection or admission from an outside hospital. For each specimen, we assessed timestamps for collection, Gram stain, identification of organisms and results of susceptibility testing. We used the antibiotic spectrum index (ASI) to assess changes in antibiotics given to patients during hospitalization and at discharge.
Results. Between October 2014 and September 2018, 70 veterans met our inclusion criteria and experienced 73 episodes of HAP. Their mean age was 66.2 years (±9 years) and 47 (67%) had chronic pulmonary disease. All-cause mortality at 30-days after specimen collection was 14%. The median time from specimen collection to Gram stain result was 0.8 days (interquartile range (IQR) 0.1-1.9) and to antibiotic susceptibility results was 2.4 days (IQR 1.5-3.3). The most common bacteria recovered were Enterobacteriaceae (20 isolates), Pseudomonas aeruginosa (11 isolates), Streptococcus spp. and Staphylococcus aureus (8 isolates each); colonization with Candida spp. was frequent (26 isolates).
